Rapporten
Verificerede nyheder om finansiering, hovedkvarterer og ledelse fra verdens mest innovative virksomheder
39 rapporter og tæller
Lumicell Appoints Marnie Curbow as Chief Executive Officer
Lumicell promoted Chief Commercial Officer Marnie Curbow to Chief Executive Officer, effective immediately, to lead the company as it enters its next phase of commercial growth.
CytoDyn Appoints Robert E. Hoffman Chief Executive Officer
CytoDyn appointed Robert E. Hoffman, who joined as its CFO in May 2025, as CEO, succeeding Dr. Jacob Lalezari, with a focus on clinical execution and financial discipline.
Verastem Oncology Appoints Michael P. Bailey President and CEO
Verastem Oncology appointed director Michael P. Bailey, who spent 16 years at AVEO Pharmaceuticals, as President and CEO effective January 1, 2027, succeeding retiring CEO Daniel Paterson.
KymaThera Raises $80M Series B for Selective PI3Kα Inhibitor
KymaThera raised an $80 million Series B led by Alta Partners to advance K-1728, an oral PI3Kα inhibitor for cancer and vascular malformations.
Altis Labs Raises $25M Series A for AI Clinical-Trial Endpoints
Altis Labs raised a $25 million Series A co-led by OrbiMed and Qiming Venture Partners USA to expand AI endpoints for oncology clinical trials.
Solstice Oncology Raises $225M Series A for Neoadjuvant Immuno-Oncology
Solstice Oncology launched with a $225 million Series A led by RA Capital Management to advance porustobart, a neoadjuvant immuno-oncology therapy.
Cloverleaf Bio Raises $33M Seed Round for RNA Cancer Therapeutics
Cloverleaf Bio closed an oversubscribed $33 million seed round to advance engineered tRNA therapeutics for liver and colorectal cancers.
Thyme Care Closes $125M+ Series E and Establishes Thyme Companies
Thyme Care raised more than $125 million in a Series E led by Morgan Health at a valuation of more than $2 billion and established Thyme Companies to build new oncology businesses.
Thyme Care Names Brad Diephuis Chief Executive Officer
Thyme Care named president and chief operating officer Brad Diephuis chief executive officer, while co-founder Robin Shah moved to executive chairman to launch new business lines.
Viser 9 rapporter • Side 1 • Kategori: all
Hold dig foran markedet
Få ugentlig indsigt leveret til din indbakke. Ingen spam, kun intelligens.